Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT-Reference-Cited by-同舟云学术

Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT

Published:2016-08 Issue:31 Volume:95 Page:e4308
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Farnebo Jacob,Wadelius Agnes,Sandström Per,Nilsson Sten,Jacobsson Hans,Blomqvist Lennart,Ullén Anders

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference27 articles.

1. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era;Jahn;Int J Cancer,2015

2. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;CA Cancer J Clin,1972

3. Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches;Cereda;Expert Opin Investig Drugs,2014

4. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study;Fizazi;Lancet Oncol,2012

5. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and Metabolic Imaging of Castration-Resistant Prostate Cancer: State of Art and Future Prospects;Current Molecular Medicine;2022-01

2. Prognostic value of ECOG performance status and Gleason score in the survival of castration-resistant prostate cancer: a systematic review;Asian Journal of Andrology;2021

3. Comparison of 68Ga-PSMA-11 PET/CT with 11C-acetate PET/CT in re-staging of prostate cancer relapse;Scientific Reports;2020-03-19

4. Repeatability of quantitative parameters of 18F-fluoride PET/CT and biochemical tumour and specific bone remodelling markers in prostate cancer bone metastases;EJNMMI Research;2017-05-15